Complex gene-swapping spawns a form of lymphoma

June 28, 2002 -- Researchers have identified how a form of lymphoma develops when large pieces of chromosomes swap locations. Their observations about how chromosome rearrangements, or translocations, cause pro-B cell lymphoma in mice offer a fresh perspective on how cancers arise from an increased "dosage" of specific genes or regions of the genome.

The studies are reported in the June 28, 2002, issue of the journal Cell by Howard Hughes Medical Institute (HHMI) investigator Frederick W. Alt, HHMI associates Chengming Zhu and Kevin D. Mills, and colleagues at Children's Hospital in Boston, Harvard Medical School, the Center for Blood Research, and Brigham and Women's Hospital.

Leukemias and lymphomas can arise when chromosomes inappropriately swap genetic material. After the genetic material is swapped, various genes are removed from their natural context and they propel cell growth because they are no longer under normal control. In some cases, more complex gene translocations (as opposed to swapping one gene for another) lead to amplification of large regions of the genome. Alt and his colleagues coined the term "complicon" -- derived from "complex translocation" -- to describe this phenomenon.

Complicons may develop when the cell's DNA repair mechanisms malfunction. When DNA repair fails, broken chromosomes can persist and recombine inappropriately with other chromosomes. This leads to chromosomal translocations where genes or whole chunks of the genome are swapped from one chromosome to another.

"Complicons are commonly seen in human carcinomas, in which very complex rearrangements cause two genes that are normally on different chromosomes to amplify together," said Alt. "To date, however, there have been no mechanistic studies that have shown how complicons arise."

Alt and his colleagues, who have been studying a specific type of DNA repair pr

Contact: Jim Keeley
Howard Hughes Medical Institute

Page: 1 2 3 4

Related biology news :

1. Complex cells likely arose from combination of bacterial and extreme-microbe genomes
2. UC Riverside to play active role in Institute for Complex Adaptive Matter
3. Complex carbohydrate found to regulate plant growth
4. The Geometry of Ecological Interactions: Simplifying Spatial Complexity
5. Complex mystery of amphibian decline calls for a new kind of science
6. Magnetic Fluids More Complex Than Previously Thought
7. Environmental Testimony: Taiwan Mega-Complex Threatens Endangered Spoonbills And Efforts To Cut Greenhouse Gases, UD Prof Says
8. Researcher Gains 30,000% Saving Using "Bargain Basement" Chemistry To Create Complex Industrially Useful Molecules
9. Second Gene Responsible For Tuberous Sclerosis Complex Identified
10. UCF brain cell research spawns hope for longer life
11. Sturgeon researchers vision spawns thriving industry

Post Your Comments:

(Date:6/11/2020)... OLDSMAR, Fla. (PRWEB) , ... June 08, 2020 ... ... increased demand for masks and other protective measures to protect workers in the ... doctors and their dedicated staffs who valiantly risk their lives every day to ...
(Date:6/5/2020)... Calif. (PRWEB) , ... June 04, 2020 , ... ... has filed a new patent application for simplified sample preparation for Next Generation ... that will greatly reduce cost, time, and complexity of sample preparation. , “I have ...
(Date:6/5/2020)... ... ... Greffex, a pioneering vaccine and gene therapy company based in Houston, Texas, ... for a global perspective to make an impact in a post pandemic world,” said ... an independent, director of the company. , “The Greffex board is excited to have ...
Breaking Biology News(10 mins):
(Date:7/18/2020)... MILWAUKEE (PRWEB) , ... July 16, 2020 , ... “We ... at Third Wave Bioactives. “It’s the only technology of its kind on the market ... flavor of onions with the protective capacity of traditional cultured ingredients, creating a natural ...
(Date:7/10/2020)... , ... July 08, 2020 , ... ... and products, announces a significant expansion of laboratory operations through its COVID-19 ... agencies implementing testing programs. , Bode-CARES provides a turnkey solution ...
(Date:7/10/2020)... ... 2020 , ... Sentien Biotechnologies, Inc., a clinical-stage biotechnology company ... Nissenson, M.D., F.A.C.P., as its Chief Medical Officer. Dr. Nissenson will join ... Dr. Nissenson serves as an Emeritus Professor of Medicine at the David ...
(Date:7/1/2020)... N.C. (PRWEB) , ... June 29, 2020 , ... ... reported year to date growth of 40% in 2020, despite many obstacles created ... technology, MedShift aims to increase revenue for its partnered medical practices and medical ...
Breaking Biology Technology:
Cached News: